# RBT-1 Phase 1b Clinical Trial in Healthy Volunteers and Subjects With CKD

> **NCT03630029** · PHASE1 · WITHDRAWN · sponsor: **Renibus Therapeutics, Inc.**

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** FeS and SnPP

## Key facts

- **NCT ID:** NCT03630029
- **Lead sponsor:** Renibus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-09-15
- **Primary completion:** 2018-11-30
- **Final completion:** 2019-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The trial has been enhanced, a new NCT(NCT03893799) listing was created.
- **Last updated:** 2020-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03630029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03630029, "RBT-1 Phase 1b Clinical Trial in Healthy Volunteers and Subjects With CKD". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03630029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*